Article
Pantothenate kinase-associated neurodegeneration (Hallervorden-Spatz syndrome).
European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society - 1 Jan 2002
Gordon Neil
Abstract excerpt
The arguments over the nomenclature of the syndrome are reviewed. Ethical considerations favour replacing the present eponyms with the title of panthothenate kinase-associated neurodegeneration (PKAN), now that more is known about the cause of the condition. The symptoms and signs of the syndrome are described, and these can present from infancy to adult life. Dystonia, involuntary movements and spasticity are...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
